(Q51800025)

12 April 2018

title

Challenges in HIV and visceral Leishmania co-infection: future research directions. (English)

1 reference

12 April 2018

author

Lut Lynen

2

1 reference

12 April 2018

Marleen Boelaert

3

1 reference

12 April 2018

author name string

Ermias Diro Ejara

1

1 reference

12 April 2018

Johan Van Griensven

4

1 reference

12 April 2018

publication date

17 August 2010

1 reference

12 April 2018

Tropical Medicine and International Health

published in

1 reference

12 April 2018

volume

15

1 reference

12 April 2018

issue

10

1 reference

12 April 2018

page(s)

1266-1267

1 reference

12 April 2018

Field evaluation of FD-DAT, rK39 dipstick and KATEX (urine latex agglutination) for diagnosis of visceral leishmaniasis in northwest Ethiopia.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02612.X

A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02612.X

Combination therapy for visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02612.X

Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02612.X

Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02612.X

Low specificities of HIV diagnostic tests caused by Trypanosoma brucei gambiense sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02612.X

Intracellular survival of Leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02612.X

Inhibition of human immunodeficiency virus type 1 assembly and release by the cholesterol-binding compound amphotericin B methyl ester: evidence for Vpu dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02612.X

Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02612.X

10.1111/J.1365-3156.2010.02612.X

21 January 2018

Identifiers

DOI

1 reference

12 April 2018

PubMed ID

20723183

1 reference

12 April 2018